Isabelle Lopez

Statistics

Publications

Citations

295

H-Index

Active since

1995

Affiliations

Assistance Publique – Hôpitaux de Paris(Current)

Centre Hospitalier Universitaire de Grenoble

Hôpital de la Timone

Université Sorbonne Paris Nord

Centre Hospitalier Annecy Genevois

Isabelle Lopez is an author at Assistance Publique – Hôpitaux de Paris specializing in medicine, cutaneous squamous cell carcinoma immunotherapy, and cancer immunotherapy.

ORCID

Publications per year

1995–2020

Publications

Phase II Study of Pembrolizumab As First-Line, Single-Drug Therapy for Patients With Unresectable Cutaneous Squamous Cell Carcinomas

E. Maubec, Marouane Boubaya, Peter Petrow et al. · Journal of Clinical Oncology · 2020 · 174 citations

Medicine, Oncology, Pharmacology +16

CIRCULATING ENDOTOXINS AND POSTREPERFUSION SYNDROME DURING ORTHOTOPIC LIVER TRANSPLANTATION

Stéphane Blanot, Marie Christine Gillon, Isabelle Lopez et al. · Transplantation · 1995 · 28 citations

Medicine, Immunology, Surgery +11

Pembrolizumab as first line therapy in patients with unresectable squamous cell carcinoma of the skin: Interim results of the phase 2 CARSKIN trial.

E. Maubec, Marouane Boubaya, Peter Petrow et al. · Journal of Clinical Oncology · 2018 · 24 citations

Medicine, Oncology, Pharmacology +17

Treatment-related knowledge and skills of patients with haemophilia and their informal caregivers

Teddy Novais, Antoine Duclos, R. Varin et al. · International Journal of Clinical Pharmacy · 2015 · 20 citations

Medicine, Hematology, Psychosocial Care +8

Pembrolizumab as first-line therapy in patients with unresectable cutaneous squamous cell carcinoma (cSCC): Phase 2 results from CARSKIN.

E. Maubec, Marouane Boubaya, Peter Petrow et al. · Journal of Clinical Oncology · 2019 · 19 citations

Medicine, Oncology, Pharmacotherapy +17

1–5 of 7